Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 413897, 10 pages
http://dx.doi.org/10.1155/2015/413897
Research Article

The Oncofetal Protein IMP3: A Novel Grading Tool and Predictor of Poor Clinical Outcome in Human Gliomas

1Division of Pathology, Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy
2Division of Pathology, Ospedale Sant’Anna, 22020 Como, Italy
3Division of Neurosurgery, Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy
4Department of Pathophysiology and Organ Transplant, University of Milan, 20122 Milan, Italy
5Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20122 Milan, Italy

Received 23 September 2014; Revised 14 November 2014; Accepted 14 November 2014

Academic Editor: Nader Pouratian

Copyright © 2015 Alessandro Del Gobbo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Alessandro Del Gobbo, Valentina Vaira, Lucia Ferrari, et al., “The Oncofetal Protein IMP3: A Novel Grading Tool and Predictor of Poor Clinical Outcome in Human Gliomas,” BioMed Research International, vol. 2015, Article ID 413897, 10 pages, 2015. https://doi.org/10.1155/2015/413897.